Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MDT | Ordinary Shares | Award | $0 | +6.94K | +22.55% | $0.00 | 37.7K | Aug 1, 2022 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MDT | Performance Share Units | Award | $0 | +17.4K | $0.00 | 17.4K | Aug 1, 2022 | Performance Share Units | 17.4K | Direct | F3, F4, F5 | ||
transaction | MDT | Stock Option (Right to Buy) | Award | $0 | +54.8K | $0.00 | 54.8K | Aug 1, 2022 | Ordinary Shares | 54.8K | $93.08 | Direct | F6 |
Id | Content |
---|---|
F1 | The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date. |
F2 | This balance increased by 410 shares due to exempt transactions such as dividend reinvestment. |
F3 | Each performance share unit represents a contingent right to receive one share of Medtronic common stock. |
F4 | The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 17,351 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. |
F5 | Vests on August 1, 2025. |
F6 | These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. |